FDA Proposes Recall Template to Communicate Drug Risks

Generic Line
A A
The FDA will test a new standardized template to quickly and clearly communicate risk to consumers during the next big recall.

To View This Article:

Login

Subscribe To Generic Line

Buy This Article Now

Add this article to your cart for $10.00